How I treat...Acne in adolescents: A strategic algorithm without antibiotic;Comment je traite... l'Acné de l'adolescent: Un algorithme stratégique sans antibiotique

Revue Medicale de Liege

Volumn 61, Issue 10, 2006, Pages 667-670

  Xhauflaire Uhoda, E ^a   Goffin, V ^a   Pierard Franchimont C ^a   Pierard G E ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Acne; Adapalene; Benzoyl peroxide; Isotretinoin; Miconazole

Indexed keywords

ANTI ACNE AGENT; ANTIBIOTIC AGENT; BENZOYL PEROXIDE; ISOTRETINOIN; MICONAZOLE; RETINOID; UNCLASSIFIED DRUG; ZYMYCAN;

ACNE; ANTIBIOTIC RESISTANCE; CLINICAL FEATURE; DRUG EFFICACY; DRUG TOLERABILITY; HUMAN; MONOTHERAPY; REVIEW; RISK FACTOR; TOPICAL TREATMENT;

ACNE VULGARIS; ADOLESCENT; ALGORITHMS; FEMALE; HUMANS; MALE; SEX FACTORS;

EID: 33847733179     PISSN: 00353663     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (32)

1. Piérard-Franchimont C, Goffin V, Arrese JE, et al. - Lymecycline and minocycline in inflammatory acne. A randomized, double-blind study on clinical and in vivo antibacterial efficacy. Skin Pharmacol Appl Skin Physiol, 2002, 15, 112-119.
2. Tan HH. - Topical antibacterial treatments for acne vulgaris. Comparative review and guide to selection. Am J Clin Dermatol, 2004, 5, 79-84.
3. Tan HH. - Antibacterial therapy for acne. A guide to selection and use of systemic agents. Am J Clin Dermatol, 2005, 6, 307-314.
4. Eady EA, Jones CE, Tipper JL, et al. - Antibiotic resistant Propionibacteria in acne : need for policy to modify antibiotic usage. BMJ, 1993, 306, 555-556.
5. Bolognia JL, Edelson RL. - Spread of antibiotic-resistant bacteria from acne patients to personal contacts - problem beyond the skin ? Lancet, 1997, 350, 972-973.
6. Bettoli V, Borghi A, Rossi R, et al. - Antibiotic resistance of propionibacteria. Four year's experience of a large number of cases in Italy. Dermatology, 2006, 212, 206-207.
7. Piérard-Franchimont C, Henry F, Fraiture AL, et al. - Split-face clinical and bio-instrumental comparison of 0.1% adapalene and 0.05% tretinoin in facial acne. Dermatology, 1999, 198, 218-222.
8. Mills Jr OH, Kligman AM, Pochi P, et al. - Comparing 2.5%, 5%, and 10% benzoyl peroxide on inflammatory acne vulgaris. Int J Dermatol, 1986, 25, 664-667.
9. Piérard GE. - Acne gymnasium : une acné fulminante dopée. Rev Med Liège, 1998, 53, 441-443.
10. Piérard-Franchimont C, Fraiture AL, Delvoye P, et al. - Les dermatoses cataméniales : une facette fréquente de la chronobiologie. Rev Med Liège, 1999, 54, 318-321.
11. Flagothier C, Piérard-Franchimont C, Piérard GE. - Acnés paroxystiques. Rev Med Liège, 2004, 59, 177-179.
12. Nikkels AF, Piérard GE. - Control of perimenstrual flares of perioral dermatitis by isotretinoin. J Dermatol Treat, 2000, 11, 97-99.
13. Degreef H, Vanden Bussche G. - Double blind evaluation of a miconazole-benzoylperoxide combination for topical treatment of acne vulgaris. Dermalogica, 1982, 164, 201-208.
14. Reinel D, Beierdorfer H. - A new drug combination for the topical treatment of acne, miconazole 2% + benzoyl peroxide 5 % versus benzoyl peroxide 5% : a double-blind study. Z Hautkr, 1985, 60, 648-656.
15. Mesquita-Guimaraes J, Ramos S, Tavares MR, et al. - A double-blind clinical trial with a lotion containing 5% benzoyl peroxide and 2% miconazole in patients with acne vulgaris. Clin Exp Dermatol, 1989, 14, 357-360.
16. Petit L, Piérard-Franchimont C, Uhoda E, et al. - Coping with mild inflammatory catamenial acne. A clinical and bioinstrumental split-face assessment. Skin Res Technol, 2004, 10, 278-282.
17. Flagothier C, Vromme V, Borgers M, et al. - Effect of a single overnight topical application of miconazole nitrate paste on acne papules. Int J Dermatol, 2006, 45, 316-319.
18. Van Cutsem JM, Thienpont D. - Miconazole a broad-spectrum antimycotic agent with antibacterial activity. Chemotherapy, 1972, 17, 392-404.
19. Xhaufflaire-Uhoda E, Vromme V, Cauwenberg G, et al. - Dynamics of skin barrier repair following topical applications of miconazole nitrate. Skin Pharmacol Physiol, in press.
20. Xhauflaire-Uhoda E, Piérard GE. - Skin capacitance imaging of acne lesions. Skin Res Technol, sous presse.
21. Piérard-Franchimont C, Gaspard V, Lacante P, et al. - A quantitative biometrological assessment of acne and hormonal evaluation in young women using a triphasic low-dose oral contraceptive containing gestodene. Eur J Contracept Reprod Health Care, 2000, 5, 275-286.
22. Goffin V, Piérard-Franchimont C, Piérard GE. - Lowette® un contraceptif pour traiter l'acné de la jeune femme. Rev Med Liège, 2003, 58, 261-263.
23. Van Vloten WA, Sigurdsson V. - Selecting an oral contraceptive agent for the treatment of acne in women. Am J Clin Dermatol, 2004, 5, 35-441.
24. Piérard-Franchimont C, Hermanns-Lê T, Piérard GE. - La peau et le temps de la grossesse. Rev Med Liège, 1999, 54, 393-400.
25. Chivot M. - Retinoid therapy for acne. A comparative review. Am J Clin Dermatol, 2005, 6, 13-19.
26. Quéreux G, Volteau C, N'Guyen JM, Dréno B. - Prospective study of risk factors of relapse after treatment of acne with oral isotretinoin. Dermatology, 2006, 212, 168-176.
27. Zouboulis CC. - The truth behind this undeniable efficacy-recurrence rates and relapse risk factors of acne treatment with oral isotretinoin. Dermatology, 2006, 212, 99-100.
28. Piérard GE, Piérard-Franchimont C. - Comment je préviens par des soins dermo-cosmétiques l'expression d'une acné qui couve. Rev Med Liège, 2005, 60, 741-743.
29. Piérard-Franchimont C, Piérard GE, D. Saint Léger D, et al. - Comparison of the kinectics of sebum secretion in young women with and without acne. Dermatologica, 1991, 183, 120-122.
30. Layton AM, Hughes BR, Macdonald Hull S, et al. - Seborrhoea : an indicator for poor clinical response in acne patients treated with antibiotics. Clin Exp Dermatol, 1992, 17, 173-175.
31. Piérard-Franchimont C, Flagothier C, Henry F, et al. - Le fond de l'air est frais... la peau va en souffrir. Skin, 2004, 7, 81-84.
32. Thirion L, Piérard-Franchimont C, Piérard GE. - Atténuer l'acné qui couve par un traitement cosmétique. Skin, 2006, 9, 37-38.